产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 | |||
| 25g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 | |||
| 25g | 98% | 现货 |
CAS No. |
1195765-45-7 |
|---|---|
中文名称 |
N-[3-[5-(2-氨基-4-嘧啶基)-2-(叔丁基)-4-噻唑基]-2-氟苯基]-2,6-二氟苯磺酰胺 |
英文名称 |
N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide |
别名 |
GSK-2118436A | GSK-2118436 | AKOS024463285 | CCG-264736 | N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide | P06 | Q413328 | Dabrafenib (Free Base) | DB08912 | DABRAFENIB [MI] | GSK2118 |
标准英文名 |
N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide |
分子式 |
C23H20F3N5O2S2 |
分子量 |
519.57 |
精确分子量 |
519.10 |
SMILES |
O=S(C1=C(F)C=CC=C1F)(NC2=CC=CC(C3=C(C4=NC(N)=NC=C4)SC(C(C)(C)C)=N3)=C2F)=O |
标准SMILES |
CC(C)(C)C1=NC(=C(S1)C1C=CN=C(N)N=1)C1C=CC=C(NS(=O)(=O)C2C(F)=CC=CC=2F)C=1F |
性状 |
White to Yellow Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
BFSMGDJOXZAERB-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Keep in dark place,Inert atmosphere,Room temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|